TargetMol

GSK-F1

Product Code:
 
TAR-T67837
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T67837-1mg1mg£221.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67837-5mg5mg£389.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67837-1mL1 mL * 10 mM (in DMSO)£522.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67837-10mg10mg£590.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67837-25mg25mg£994.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67837-50mg50mg£1,452.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67837-100mg100mg£2,151.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
GSK-F1 is a selective small molecule inhibitor of Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα), pIC50=8.3.
CAS:
1384097-27-1
Molecular Weight:
603.52
Pathway:
PI3K/Akt/mTOR signaling
Purity:
0.9935
SMILES:
O=C1C=2C=C(C=CC2N=C(N)N1C=3C=CC=CC3C(F)(F)F)C=4C=NC(OC)=C(C4)S(=O)(=O)NC5=CC=C(F)C=C5F
Target:
PI4K

References

Leivers AL, et al. Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIII?) inhibitors as anti hepatitis C (HCV) agents. J Med Chem. 2014 Mar 13;57(5):2091-106.